Dual repair modulation reverses Temozolomide resistance in vitro

Molecular Cancer Therapeutics

Volumn 3, Issue 2, 2004, Pages 123-127

  Barvaux, Vincent A ^a   Ranson, Malcolm ^a   Brown, Robert ^b   McElhinney, R Stanley ^c   McMurry, T Brian H ^c   Margison, Geoffrey P ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; 6 O ALKYLGUANINE DNA ALKYLTRANSFERASE; 6 O METHYLGUANINE; ALKYLATING AGENT; LOMEGUATRIB; PROTEIN MLH1; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DNA ADDUCT; DNA METHYLATION; DNA REPAIR; DRUG SENSITIZATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MISMATCH REPAIR; OVARY TUMOR; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN EXPRESSION; TUMOR CELL LINE;

BASE PAIR MISMATCH; CARRIER PROTEINS; CELL LINE, TUMOR; DACARBAZINE; DNA DAMAGE; DNA REPAIR; DRUG RESISTANCE; GUANINE; HUMANS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE;

EID: 4444351655     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. 6-methylguanine in wild-type Escherichia coli and in a strain deficient in ada-methyltransferase. J Bacteriol, 1991;173:1201-7.
2. Fink D, Aebi S, Howell SB. The role of DNA mismatch repair in drug resistance. Clin Cancer Res, 1998;4:1-6.
3. Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature, 2001;411:366-74.
4. Mitchell RJ, Farrington SM, Dunlop MG, Campbell H. Mismatch repair genes hMLH1 and hMSH2 and colorectal cancer: a HuGe review. Am J Epidemiol, 2002;156:885-902.
5. Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene, 2002;21:5427-40.
6. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res, 2001;61:3225-9.
7. Sorm F, Piskala A, Cihak A, Vesely J. 5-Azacytidine, a new, highly effective cancerostatic. Experientia, 1964;20:202-3.
8. Juttermann R, Li E, Jaenisch R. Toxicity of 5-aza-2′-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation. Proc Natl Acad Sci USA, 1994;91:11797-801.
9. Jeggo PA, Holliday, R. Azacytidine-induced reactivation of a DNA repair gene in Chinese hamster ovary cells. Mol Cell Biol, 1986;6:2944-9.
10. 6-alkylguanine-DNA-alkyltransferase activity in mouse Ha821 cells. Carcinogenesis, 1989;10:1879-82.
11. Plumb JA, Strathdee G, Sludden J, Kaye SB, Brown, R. Reversal of drug resistance in human tumor xenografts by 2′-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter. Cancer Res, 2002;60:6039-44.
12. Gerson SL. Clinical relevance of MGMT in the treatment of cancer. J Clin Oncol, 2002;20:2388-99.
13. Glassner BJ, Weeda G, Allan JM, Broekhof JL, Carls NH, Donker I, et al. DNA repair methyltransferase (Mgmt) knockout mice are sensitive to the lethal effects of chemotherapeutic alkylating agents. Mutagenesis, 1999;14:339-47.
14. Kawate H, Itoh R, Sakumi K, Nakabeppu Y, Tsuzuki T, Ide F, et al. A defect in a single allele of the Mlh1 gene causes dissociation of the killing and tumorigenic actions of an alkylating carcinogen in methyltransferase-deficient mice. Carcinogenesis, 2000;21:301-5.
15. 6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc Natl Acad Sci USA, 1990;87:5368-72.
16. 6-(hetarylmethyl)guanines having basic rings in the side chain. J Med Chem, 1998;41:5265-71.
17. Middleton MR, Kelly J, Thatcher N, Donnelly DJ, McElhinney RS, Mc Murry TB, et al. O(6)-(4-bromothenyl)guanine improves the therapeutic index of temozolomide against A375M melanoma xenografts. Int J Cancer, 2000;85:248-52.
18. Strathdee G, MacKean MJ, Illand M, Brown R. A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer. Oncogene, 1999;18:2335-41.
19. Guesdon JL, Ternynck T, Avrameas, S. The use of avidin-biotin interaction in immunoenzymatic techniques. J Histochem Cytochem, 1979;27:1131-9.
20. 6-alkylguanine- DNA-alkyltransferases. Curr Gene Ther, 2002; 2:1-8.
21. Rivard GE, Momparler RL, Demers J, Benoit P, Raymond R, Lin K, et al. Phase I study on 5-aza-2′-deoxycytidine in children with acute leukemia. Leuk Res, 1981;5:453-62.